Agenda
Please note: Timings are in CET (Central European Time)
- Session 4: Sustainability and the BPR
-
Updates on the high-level round table discussions and the likely impacts of the Reach/CLP reviews on the biocides sector
- Recent developments in the REACH/CLP review
- Links between Reach and biocides regulation
- New hazard classes
- Possible implications for active substance approval and product authorisation
Paul Krajnik
Chair of the ECHA Management Board and Deputy Director Chemicals and Biocides, Ministry for Climate Action, Environment, Energy, Mobility, Innovation and Technology, Austria -
The EU Chemical Strategy for Sustainability (CSS): What does it mean for biocides?
- The Green Deal and CSS: compliance of biocides?
- Impact assessment and socio-economic analysis (SEA)
- A strategy for biocides
-
The Blue Angel ecolabel approach to antifouling
- 100 non-biocidal antifouling systems identified for the German market
- 14 different mechanisms of action
- Proofs of concept and banned substances
Bernd Daehne
Director of Antifouling Research Station, Dr. Brill + Partner - Institute for Antifouling and Biocorrosion -
Q&A
-
Refreshment break
- Session 4: Sustainability and the BPR, continued
-
Legal perspective: Implications of sustainability regulations for companies in the biocides sector
- Context and drivers for sustainability
- Current successes, difficulties and opportunities
-
Biocides and sustainable use
-
Panel discussion on biocides and sustainable use
-
Lunch
-
Chemical Watch demo
- Session 5: The assessment of endocrine disrupting chemicals under the BPR
-
Scientific criteria to identify endocrine chemicals
- What are the new methods and their implementation within regulatory assessment?
- How to build the weight of evidence?
- Why is mechanistic toxicology required for ED assessment?
- Endocrine activity versus adverse outcome?
-
The latest developments and significant legal issues arising on ED assessments
- Are the BPR’s ED criteria implementable?
- Data rights issues
- Impact of chemicals strategy for sustainability
- ED as a new hazard class under the Regulation on the classification, labelling and packaging of substances and mixtures (CLP)
- One substance, one assessment
-
Q&A
-
Refreshment break
- Session 6: Efficacy updates
-
Efficacy evaluation of disinfectants PT 1 to 5, PT 21 and treated articles PT 10 based on current development and Echa efficacy guidance including biofilm-activity testing
- Overview of current activity test methods for PT 1 – 5, PT 10 and PT 21
- Update on latest resistance developments
- Biofilm activity methods – quo vadis?
Florian H H Brill
Owner and Managing Director, Dr Brill + Partner GmbH, Institut für Hygiene und Mikrobiologie -
Efficacy – beyond the guidance
- The applicant
- The assessor
- The efficacy method provider
-
Simulated use test and field trial for PT5 claims and applications
- PT 5 claim matrix and Echa test requirements
- Simulated use test – validation requirements (case study: UBA test)
- Robust field trial experimental design (case study: animal drinking water facility)
-
Q&A
-
End of conference
.jpg)
.jpg)
.jpg)
